IMGM Laboratories GmbH announces the appointment of Dr. Michael Bonin as Managing Director

IMGM Laboratories GmbH – Press Release
Martinsried, Germany, August 22, 2014

The genomic service provider IMGM Laboratories GmbH is pleased to announce Dr. Michael Bonin (40) as additional Managing Director effective August 1st 2014. Michael Bonin will head the scientific and technical development of the IMGM Laboratories GmbH activities and will direct the business of IMGM together with the Managing Director and Founder Dr. Hanns-Georg Klein.

Michael Bonin

Dr. Michael Bonin New Managing Director at IMGM Laboratories GmbH

“We are proud to have an exceptional biologist and experienced manager such as Dr. Michael Bonin joining the Executive Board of IMGM. His recognized scientific and technological expertise and management skills as well as the highly innovative genomic service strategies, he has developed with his team in Tuebingen will add a significant value to IMGM Laboratories GmbH.”, comments Dr. Klein.

Dr. Michael Bonin, Managing Director at IMGM from August 1st 2014: “I am very much looking forward to working together with the excellent and experienced IMGM team on the continued development of technologies and methods which will help to find the best genomic solutions for our customers. Especially intriguing for me is the broad spectrum of projects including such current topics as pharmaceutical research, biomarker discovery and companion diagnostics which generates a fascinating working environment.”

About Michael Bonin

Previously, Michael Bonin served as Director of MFTServices, one of the leading academic core facilities for expression profiling and genotyping in Germany located at the Institute of Medical Genetics and Applied Genomics, Medical Faculty, University Tuebingen. At MFTServices he was responsible for all parts of technological strategy and all business development activities. Michael Bonin holds a degree in Genetics and is author of over 120 scientific articles with an overall impact factor of more than 600. His scientific expertise includes neurodegenerative processes, human genetics applications as well as microarray and next generation sequencing technologies.

About IMGM Laboratories GmbH

IMGM is one of the leading outsourcing partners and advanced genomic service provider  for  demanding  projects  with  a  focus  on  Metagenomics,  Biomarker Discovery, Biodistribution and pharmacogenetics. IMGM offers complete solutions to customers from pharma,  diagnostics,  biotech  and  academia  according  to  the project requirements. Experience, motivation and a strong background in molecular genetics and medical diagnostics lie at the heart of its high quality services. IMGM combines state-of-the-art technologies with complex data analysis to deliver meaningful results in an easy-to-understand format. Furthermore, IMGM offers preparation of comprehensive GxP-ready analytical plans and reports to provide excellent documentation towards the relevant agencies. This makes IMGM a valuable partner for conducting (pre-) clinical studies and rounds off the company portfolio of complete genomic services.

For more information on IMGM’s service portfolio, please visit www.IMGM.com.

Contacts

IMGM Laboratories GmbH
Dr. Aljoscha Kleinhammer
Sales & Marketing Coordinator
Bunsenstrasse 7a
82152 Martinsried, Germany
phone:  +49 89-4524667-0
E: aljoscha.kleinhammer@imgm.com